Purespring Therapeutics Secures £80M to Advance Kidney Gene Therapies
Purespring Therapeutics, a pioneering biotech firm, has successfully raised £80 million. This funding marks a significant milestone in developing innovative gene therapies for kidney diseases.As kidney diseases continue to pose…



